US Patent 8357809 Acyclic I
Patent 8357809 was granted and assigned to Bristol-Myers Squibb on January, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+38 characters)
Article
Patent abstract
A compound of formula I
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08357809 Acyclic I US Patent 8357809 Acyclic I
Infobox
Patent Number
0835780900
Patent Number
835780900
Edits on 27 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
083578090
Date of Patent
January 22, 2013
0Patent Application Number
130479980
Date Filed
March 15, 2011
0Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
083578090
Date of Patent
January 22, 2013
0Patent Application Number
130479980
Date Filed
March 15, 2011
0Patent Primary Examiner
Edits on 15 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08357809 Acyclic I
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08357809
Date of patent
January 22, 2013
Patent application number
13047998
Date Filed
March 15, 2011
Patent primary examiner
Find more entities like US Patent 8357809 Acyclic I
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
